Dr. Danielle Townsley is a Staff Clinician and Primary Investigator in the Hematology Branch of the National Heart Lung and Blood Institute (NHLBI) at the Clinical Center of the National Institutes of Health in Bethesda, Maryland. She received a Bachelor’s Degree at the University of California, San Diego in 1999 and a Master’s Degree in Epidemiology from the University of Edinburgh, Scotland in 2002. She completed her MD in 2006 and a residency in Internal Medicine at George Washington University in 2009. In 2011, she completed her hematology fellowship at the NIH where she trained under the mentorship of Drs. Neal Young and Phillip Scheinberg.
Currently she conducts her research in the laboratory of Dr. Neal Young, Chief of the Hematology Branch of NHLBI. Dr. Townsley’s research interests include the pathophysiology of marrow failure syndromes and the use of eltrombopag, a blood growth factor to treat aplastic anemia. She also studies familial causes of bone marrow failure, such as telomere diseases or dyskeratosis congenita, and the impact of inherited and acquired gene mutations on the pathophysiology of bone marrow failure. She is the principle investigator for multiple trials that utilize eltrombopag for aplastic anemia and myelodysplastic syndromes, as well as clinical trials administering the sex hormone, danazol for patients with telomere disorders.